» Articles » PMID: 21300460

Clinical Outcomes of 174 Nasopharyngeal Carcinoma Patients with Radiation-induced Temporal Lobe Necrosis

Overview
Specialties Oncology
Radiology
Date 2011 Feb 9
PMID 21300460
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To retrospectively study the clinical outcomes of nasopharyngeal carcinoma patients with radiation-induced temporal lobe necrosis (TLN) treated with steroids, surgery, or observation only.

Methods And Patients: We performed a retrospective analysis of 174 consecutive patients diagnosed with TLN between 1990 and 2008. Before 1998, symptomatic patients were treated with oral steroids, while asymptomatic patients were treated conservatively. After 1998, most symptomatic and asymptomatic patients with a large volume of necrosis were treated by intravenously pulsed-steroid therapy with a standardized protocol. We examined factors affecting grade 4 complication-free survival and overall survival. Outcomes of the three treatment groups, those receiving conservative treatment, those receiving oral steroid, and those receiving intravenous pulse steroid, were compared.

Results: The mean follow-up time was 115 months. Rates of grade 4 complication-free survival at 2 years and at 5 years after diagnosis of TLN were 72.2% and 54.1%, respectively. The 2-year and 5-year overall survival rates were 57.5% and 35.4%, respectively. Multivariate analysis revealed that being symptomatic at diagnosis (relative risk [RR], 4.5; p = 0.0001), re-irradiation of the nasopharynx (NP) (RR, 1.56; p = 0.008), salvage brachytherapy to the NP (RR, 1.75; p = 0.012), and a short latency period before the diagnosis of TLN (RR, 0.96, p < 0.0001) were independent prognosticators of poor grade 4 complication-free survival. Patients with all four factors had a 100% risk of developing grade 4 complications within 5 years; whereas if no factor was present, the risk was 12.5%. Intravenous pulse steroid therapy was associated with a higher clinical response rate compared with conventional steroid therapy (p < 0.0001); however, it did not affect complication-free survival in multivariate analysis.

Conclusions: TLN patients with good prognosticators could be observed without active treatment. Although treatment with intravenously pulsed steroid was associated with better clinical response than conventional steroid delivery, it did not affect the complication-free survival rate of TLN patients.

Citing Articles

Automated deep learning-assisted early detection of radiation-induced temporal lobe injury on MRI: a multicenter retrospective analysis.

Yang F, Hu R, Hu J, Zhao L, Zhang Y, Mao Y Eur Radiol. 2025; .

PMID: 40050455 DOI: 10.1007/s00330-025-11470-y.


Endoscope-assisted treatment for delayed cystic radiation necrosis after stereotactic radiosurgery for metastatic brain tumors: illustrative cases.

Shoda K, Nishiwaki T, Yamada T, Nakayama N, Ohe N J Neurosurg Case Lessons. 2024; 8(16).

PMID: 39401467 PMC: 11488374. DOI: 10.3171/CASE24250.


MRI-based radiomics models predict cystic brain radionecrosis of nasopharyngeal carcinoma after intensity modulated radiotherapy.

Hou J, He Y, Li H, Lu Q, Lin H, Zeng B Front Neurol. 2024; 15:1344324.

PMID: 38872826 PMC: 11169923. DOI: 10.3389/fneur.2024.1344324.


Cost-effectiveness analysis of bevacizumab for cerebral radiation necrosis treatment based on real-world utility value in China.

Luo S, Lai S, Wu Y, Hong J, Lin D, Lin S Strahlenther Onkol. 2024; 200(9):805-814.

PMID: 38829437 DOI: 10.1007/s00066-024-02242-6.


Evolution of radiation-induced temporal lobe injury after intensity-modulated radiation therapy in nasopharyngeal carcinoma: a large cohort retrospective study.

Hou J, He Y, Li H, Ai Z, Lu Q, Zeng B Radiat Oncol. 2024; 19(1):9.

PMID: 38243277 PMC: 10797916. DOI: 10.1186/s13014-024-02400-1.